ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Dr. Nicholas Kealoha’s “Lyme: The Unexpected Illness – Solved” Hits #1 Bestseller on Amazon

Revolutionary Book Offers Hope and Healing for Over 300,000 Annual Lyme Disease Sufferers

Dr. Nicholas Kealoha’s groundbreaking book, “Lyme: The Unexpected Illness – Solved,” has reached #1 in the Chronic Fatigue Syndrome category on Amazon.com, #2 in the Musculoskeletal Diseases (Kindle Store) category, and #4 in the Mind-Body Connection category.

The book addresses one of modern medicine’s most misunderstood conditions, offering answers to the estimated 300,000+ Americans infected with Lyme disease each year. Many people go undiagnosed, misdiagnosed, or dismissed by the medical establishment.

Drawing from over 20 years of research and thousands of clinical hours, Dr. Kealoha challenges outdated medical assumptions and introduces readers to the Neuro-Energetic Stimulation System (NESS). This revolutionary, drug-free therapy targets the root causes of Lyme disease deep within the brain.

Dr. Kealoha states, “NESS represents a shift in how we understand and treat chronic illness—not by suppressing symptoms, but by restoring the brain’s ability to heal. My hope is that this book opens the door to a new era of recovery for people who have felt dismissed, misdiagnosed, or told there is no way forward.”

“Lyme: The Unexpected Illness – Solved” provides patients and healthcare providers with:

  • The hidden history of Lyme disease and why it often remains undiagnosed for years
  • Critical information about why standard tests fail and what patients need to know for accurate diagnosis
  • The truth about chronic Lyme disease (CLD) that mainstream medicine often overlooks
  • Explanations of why antibiotics frequently fail and may even worsen long-term symptoms
  • Insights into how Lyme mimics over 300 other diseases, including fibromyalgia, MS, and depression
  • An introduction to NESS: a cutting-edge, drug-free therapy offering new hope
  • Real patient stories documenting journeys from misdiagnosis to full recovery
  • Natural therapies and neurobiological insights to support healing and resilience

For those living with chronic illness, mystery symptoms, or the devastating effects of Lyme disease, this book offers clarity, hope, and a scientifically grounded path forward—one that treats the whole person, not just a list of symptoms.

About the Author

Dr. Nicholas Kealoha, MD, PhD, DAOM, Director of Neurology at The Einstein Medical Institute, Triple-degree Neuroscientist, Award-Winning Physician, Author, and Co-Inventor of the patented Neuro Energetic Stimulation System® (NESS)—a revolutionary technology that combines ten scientifically proven, non-invasive treatments into one transformative experience. He holds a PhD in Neuroscience and another PhD in Acupuncture and Oriental Medicine, with over 20 years of research experience.

Dr. Nick is a member of the South Florida Crisis Intervention Team (SFCIT) and was featured on American Milestones for his groundbreaking contributions to neuroscience.

He trains physicians, dentists, and healthcare professionals in advanced diagnostic techniques, emphasizing the emotion-brain-body connection and root-cause medicine.

Dr. Nick continues to inspire both patients and practitioners with his unwavering commitment to healing, innovation, and the fusion of science with holistic insight.

“Lyme: The Unexpected Illness – Solved” is available in paperback and Kindle formats on Amazon at: https://www.amazon.com/Lyme-Dr-Nicholas-Kealoha-DAOM-ebook/dp/B0FK1YGYD1/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.14
+0.00 (0.00%)
AAPL  266.25
+0.00 (0.00%)
AMD  206.02
+0.00 (0.00%)
BAC  51.00
+0.00 (0.00%)
GOOG  289.98
+0.00 (0.00%)
META  589.15
+0.00 (0.00%)
MSFT  478.43
+0.00 (0.00%)
NVDA  180.64
+0.00 (0.00%)
ORCL  210.69
+0.00 (0.00%)
TSLA  395.23
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.